Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

VLR199

product1 mentionslast seen Oct 13, 2026

Ligand trap therapy designed to replicate Winrevair's ActRIIA mechanism of action for pulmonary arterial hypertension.

Relationships 3

Relationship

VLR199depends onActRIIA ligand trap

85% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 13, 2026Alaunos Therapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.02: Unregistered Sales of Equity Securities; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 7.01: Regulation FD Disclosure; Item 9.01: Financial Statements and Exhibits
VLR199 Designed to replicate Winrevair's clinically proven ActRIIA MoA